No Data
Is It a Wise Decision to Hold Healthpeak Properties Stock Now?
Scotiabank Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $24
Scotiabank analyst Nicholas Yulico maintains $Healthpeak Properties(DOC.US)$ with a buy rating, and adjusts the target price from $22 to $24.According to TipRanks data, the analyst has a success
Scotiabank Reaffirms Their Buy Rating on Healthpeak Properties (DOC)
Scotiabank Adjusts Healthpeak Properties Price Target to $24 From $23
Real Estate Stocks Start One of the Worst Months for Equities on a Strong Note
Looking Into Healthpeak Properties's Recent Short Interest